Atlas Trials

Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC

Clinical trial NCT06483009 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06483009
Sponsor
Shanghai Chest Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer
Start date
2024-10-01
Primary completion
2027-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.